ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1584

Evaluation of Adverse Childhood Experiences in Systemic Sclerosis: Prevalence and Patient Characteristics

Samuel Good1, Nahal Ghanoongooi1, Ju Young Lee2, Arissa Young3 and Elizabeth Volkmann1, 1David Geffen School of Medicine at University of California, Los Angeles, Department of Medicine, Division of Rheumatology, Los Angeles, CA, 2David Geffen School of Medicine at University of California, Los Angeles, Department of Medicine, Los Angeles, CA, 3UCLA, Los Angeles, CA

Meeting: ACR Convergence 2025

Keywords: Epidemiology, Systemic sclerosis, Trauma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: There is growing evidence that trauma, and in particular adverse childhood experiences (ACEs), play a role in the pathogenesis and exacerbation of systemic autoimmune disease.1 ACEs likely affect autoimmunity through multiple pathways, including pro-inflammatory processes and associations with psychosocial influences on the development of autoimmunity, such as substance use and mental health disorders. To date, no studies have evaluated the association between ACEs and disease manifestations in systemic sclerosis (SSc). The purpose of this study is to evaluate the prevalence of ACEs in SSc patients and to describe the clinical characteristics of patients with SSc with high adversity.

Methods: We recruited consecutive patients who met 2013 ACR/EULAR criteria for SSc seen in our UCLA Scleroderma Center from September 4, 2024 to April 9, 2025. The Adverse Childhood Experiences Questionnaire (ACE-Q), was administered to assess the frequency of ACEs experienced by respondents.2 The ACE-Q categorizes ACEs into 2 subdomains: abuse/neglect and household dysfunction. Descriptive statistics were used to demonstrate the demographic and clinical characteristics of patients with SSc with high vs. low-moderate total ACE-Q scores based on the validated threshold for high adversity (4 or more ACEs). This threshold is associated with significantly elevated risk for severe and complex health problems.2

Results: Among 98 patients with SSc, 85 (86.7%) were female, 63 (64.3%) identified as White, 34 (34.6%) had diffuse cutaneous disease, and 59 (60.2%) had ILD (Table 1). In the total SSc population, 63 (64.2%) patients reported at least one ACE, and 22 (22.4%) reported 4 or more ACEs (Table 1). The mean number of ACEs was 2.02 (SE 0.23) for the entire SSc cohort (Figure 1). The proportion of patients with ILD was numerically higher in the high adversity compared with low to moderate adversity groups (68.2% vs. 57.9%, respectively).

Conclusion: The majority of patients with SSc reported at least one ACE, and the prevalence of high adversity was greater in SSc patients compared with the general population in the US (22.4% vs. 17.3%, respectively).3 The high prevalence of ACEs and, in particular high adversity, in this SSc cohort highlights the need for further research into the effects of trauma on SSc pathogenesis. Moreover, the finding that high adversity was more prevalent in patients with ILD warrants future investigation into the relationship between trauma and the diverse clinical phenotypes of SSc.Citations1. Ploesser M, et al. The link between traumatic stress and autoimmune rheumatic diseases: A systematic scoping review. Semin Arthritis Rheum. 2024;69:152558. doi:10.1016/j.semarthrit.2024.1525582. Felitti VJ, et al. Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults: The Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine. 1998;14(4):245-258. doi:10.1016/S0749-3797(98)00017-83. Swedo EA, et al. Prevalence of Adverse Childhood Experiences Among U.S. Adults – Behavioral Risk Factor Surveillance System, 2011-2020. MMWR Morb Mortal Wkly Rep. 2023;72(26):707-715. doi:10.15585/mmwr.mm7226a2

Supporting image 1Table 1: Baseline Characteristics of SSc Population, Stratified by Low to Moderate versus High Adversity.

Supporting image 2Figure 2: Bar Graph of Mean number of ACEs, Stratified by Low to Moderate Adversity (0-3 ACEs) as Compared to High Adversity (4+ ACEs).


Disclosures: S. Good: None; N. Ghanoongooi: None; J. Lee: None; A. Young: None; E. Volkmann: None.

To cite this abstract in AMA style:

Good S, Ghanoongooi N, Lee J, Young A, Volkmann E. Evaluation of Adverse Childhood Experiences in Systemic Sclerosis: Prevalence and Patient Characteristics [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-adverse-childhood-experiences-in-systemic-sclerosis-prevalence-and-patient-characteristics/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-adverse-childhood-experiences-in-systemic-sclerosis-prevalence-and-patient-characteristics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology